CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-25 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +1,385.7 | 2,139.14 | ||
| 2024-04-25 | West Nadja Director | Grant or award · Deferred Share Units | +1,385.7 | 5,093.68 | ||
| 2024-04-25 | WEINBERGER MARK A Director | Grant or award · Deferred Share Units | +1,385.7 | 9,129.35 | ||
| 2024-04-25 | MULCAHY ANNE M Director | Grant or award · Deferred Share Units | +1,385.7 | 21,470.62 | ||
| 2024-04-25 | McClellan Mark B. Director | Grant or award · Deferred Share Units | +1,385.7 | 17,867.72 | ||
| 2024-04-25 | Joly Hubert Director | Grant or award · Deferred Share Units | +1,385.7 | 6,464.15 | ||
| 2024-04-25 | Johnson Paula A Director | Grant or award · Deferred Share Units | +1,385.7 | 2,858.55 | ||
| 2024-04-25 | Doudna Jennifer A Director | Grant or award · Deferred Share Units | +1,385.7 | 8,081.64 | ||
| 2024-03-13 | Broadhurst Vanessa EVP, Global Corp Affairs | Sale | −8,891 | $162.16 | $1.4M | 15,043 |
| 2024-03-05 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +491.45 | $159.80 | $79K | 491.45 |
| 2024-03-05 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +261.99 | $159.80 | $42K | 753.45 |
| 2024-03-05 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +234.67 | $159.80 | $37K | 8,787.74 |
| 2024-02-15 | Wolk Joseph J Exec VP, CFO | Grant or award · Employee Stock Options (Right to Buy) | +95,197 | 95,197 | ||
| 2024-02-15 | Wolk Joseph J Exec VP, CFO | Grant or award · Restricted Share Units | +5,913 | 5,913 | ||
| 2024-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Employee Stock Options (Right to Buy) | +29,275 | 29,275 | ||
| 2024-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Restricted Share Units | +1,819 | 1,819 | ||
| 2024-02-15 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Grant or award · Employee Stock Options (Right to Buy) | +76,981 | 76,981 | ||
| 2024-02-15 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Grant or award · Restricted Share Units | +4,782 | 4,782 | ||
| 2024-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Grant or award · Employee Stock Options (Right to Buy) | +49,658 | 49,658 | ||
| 2024-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Grant or award · Restricted Share Units | +3,085 | 3,085 |
Page 26 of 33 · 658 trades